Inex Pharmaceuticals
INEX receives Protiva Biotherapeutics' statement of claim
Published in Law and Health Weekly, October 14th, 2006
Protiva, a private biotechnology company, was spun-out from INEX in 2001 along with certain intellectual property rights relating to gene therapy technology. INEX holds a minority interest in Protiva.
This claim, filed in a California court, appears to be substantively the same as one of the allegations made in the suit filed by Protiva in British Columbia Supreme Court in March 2006. INEX filed a statement of defense and counterclaim against...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Amphora Discovery
Amphora Discovery forms two market-driven business units - Center Hospital Pitie Salpetriere, Paris, France
Researchers from France, the United States and the United Kingdom provide details of new studies and findings in the area of HIV/AIDS - Community Oncology Alliance
Cancer community gathers on Capitol Hill to save cancer care - Identa
Drug detection products made by IDenta earn acceptance of Chinese Federal Police - Indiana University, U.S.
Bioethics program in predictive health is established at Indiana University - Louisiana State University, U.S.
Data from the United States and Canada advance knowledge in HIV/AIDS research - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
